BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33794208)

  • 1. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
    Bowden SJ; Bodinier B; Kalliala I; Zuber V; Vuckovic D; Doulgeraki T; Whitaker MD; Wielscher M; Cartwright R; Tsilidis KK; Bennett P; Jarvelin MR; Flanagan JM; Chadeau-Hyam M; Kyrgiou M;
    Lancet Oncol; 2021 Apr; 22(4):548-557. PubMed ID: 33794208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus.
    Chen D; Enroth S; Liu H; Sun Y; Wang H; Yu M; Deng L; Xu S; Gyllensten U
    Oncotarget; 2016 Jul; 7(27):42216-42224. PubMed ID: 27285765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels.
    Ramachandran D; Schürmann P; Mao Q; Wang Y; Bretschneider LM; Speith LM; Hülse F; Enßen J; Bousset K; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Tarbiat J; Runnebaum I; Dürst M; Hein A; Koch M; Ruebner M; Ekici A; Beckmann MW; Fasching PA; Luyten A; Petry KU; Hillemanns P; Dörk T
    Int J Cancer; 2020 Nov; 147(9):2458-2468. PubMed ID: 32580243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection.
    Ferrera A; Olivo A; Alaez C; Melchers WJ; Gorodezky C
    Hum Biol; 1999 Jun; 71(3):367-79. PubMed ID: 10380373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study of susceptibility loci for cervical cancer.
    Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
    J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
    Chen D; Gyllensten U
    Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix.
    Ferguson R; Ramanakumar AV; Koushik A; Coutlée F; Franco E; Roger M;
    Int J Cancer; 2012 Aug; 131(3):E312-9. PubMed ID: 22095460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association study of prevalent and persistent cervical high-risk human papillomavirus (HPV) infection.
    Adebamowo SN; Adeyemo AA; Rotimi CN; Olaniyan O; Offiong R; Adebamowo CA;
    BMC Med Genet; 2020 Nov; 21(1):231. PubMed ID: 33225922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study.
    Zoodsma M; Nolte IM; Schipper M; Oosterom E; van der Steege G; de Vries EG; te Meerman GJ; van der Zee AG
    J Med Genet; 2005 Aug; 42(8):e49. PubMed ID: 16061555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genomic variants at PAX8 and PBX2 with cervical cancer risk.
    Ramachandran D; Wang Y; Schürmann P; Hülse F; Mao Q; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Müller F; Runnebaum I; Hein A; Koch M; Ruebner M; Beckmann MW; Fasching PA; Luyten A; Dürst M; Hillemanns P; Dörk T
    Int J Cancer; 2021 Apr; ():. PubMed ID: 33905146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
    Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women.
    Kohaar I; Hussain S; Thakur N; Tiwari P; Nasare V; Batra S; Singh V; Bhambani S; Das BC; Sarkar DP; Bharadwaj M
    Hum Immunol; 2009 Apr; 70(4):222-9. PubMed ID: 19272325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus.
    Simões RT; Gonçalves MA; Castelli EC; Júnior CM; Bettini JS; Discorde ML; Duarte G; Quintana SM; Simões AL; Moreau P; Carosella ED; Soares EG; Donadi EA
    Mod Pathol; 2009 Aug; 22(8):1075-82. PubMed ID: 19407850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population.
    Chan PK; Cheung JL; Cheung TH; Lin CK; Siu SS; Yu MM; Tang JW; Lo KW; Yim SF; Wong YF; To KF; Ng HK; Chung TK
    Gynecol Oncol; 2007 Jun; 105(3):736-41. PubMed ID: 17379283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.
    Carozzi F; Gillio-Tos A; Confortini M; Del Mistro A; Sani C; De Marco L; Girlando S; Rosso S; Naldoni C; Dalla Palma P; Zorzi M; Giorgi-Rossi P; Segnan N; Cuzick J; Ronco G;
    Lancet Oncol; 2013 Feb; 14(2):168-76. PubMed ID: 23261355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA class I and II genes with cervical cancer susceptibility in a Han Chinese population.
    Yao Y; Yan Z; Li C; Zhang S; Liu S; Zhang X; Shi L; Liu W; Shi L; Yao Y
    HLA; 2024 Jan; 103(1):e15340. PubMed ID: 38212262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.
    Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F
    BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic variants INSIG2 rs6726538, HLA-DRB1 rs9272143, and GCNT1P5 rs7780883 contribute to the susceptibility of cervical cancer in the Bangladeshi women.
    Hasan ME; Matin M; Haque ME; Aziz MA; Millat MS; Uddin MS; Moghal MMR; Islam MS
    Cancer Med; 2021 Mar; 10(5):1829-1838. PubMed ID: 33586351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease.
    Zoodsma M; Nolte IM; Te Meerman GJ; De Vries EG; Van der Zee AG
    Int J Oncol; 2005 Mar; 26(3):769-84. PubMed ID: 15703836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women.
    Helland A; Olsen AO; Gjøen K; Akselsen HE; Sauer T; Magnus P; Børresen-Dale AL; Rønningen KS
    Int J Cancer; 1998 Mar; 76(1):19-24. PubMed ID: 9533756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.